BACKGROUND: This study aims to identify which among the metabolic syndrome (MS) definitions are closely associated with pathological levels of leptin, adiponectin, resistin, tumour necrosis alpha (TNF-alpha) and C-reactive protein (CRP) among type 2 diabetics. MATERIALS AND METHODS: Three hundred and five (160 males; 145 females) adult type 2 diabetic Saudis participated in this cross-sectional study. Leptin, adiponectin, resistin, TNF-alpha and CRP were analysed, using enzyme-linked immunosorbent assays (ELISA). Each participant was screened for MS based on the definitions of WHO, AHA/NHLBI and IDF. RESULTS: IDF holds the most identified patients [190 (62.3%)] in both, males [107 (66.9%)], and females [83 (57.2%)]. In males, hyperleptinemia, hypoadiponectinemia and hyperresistinemia were strongest in the AHA/NHLBI-defined MS [odds ratio (95% confidence interval 'CI') of 2.03 (1.05-3.93); 1.31 (0.55-3.1); 1.63 (0.42-6.4) respectively]. The risk of elevated CRP was highest on the WHO definition [odds ratio (95% CI) of 2.04 (0.46-9.04)]. In females, the IDF-defined MS has the strongest association in all four parameters: odds ratio (95% CI), as follows: leptin [2.09 (0.14-30.71)]; adiponectin [6.00 (0.47-76.17)]; resistin [0.47 (0.18-1.23)] and CRP [3.07 (0.21-45.10)]. CONCLUSION: Gender differences exist in assessing the risk of various adipocytokine abnormalities in relation to the various criteria. This study supports the use of IDF definition among females and AHA/NHLBI in males in studies involving MS and obesity, since these definitions hold stronger predicting powers in detecting pathological levels of key adipocytokines. 2007 John Wiley & Sons, Ltd
BACKGROUND: This study aims to identify which among the metabolic syndrome (MS) definitions are closely associated with pathological levels of leptin, adiponectin, resistin, tumour necrosis alpha (TNF-alpha) and C-reactive protein (CRP) among type 2 diabetics. MATERIALS AND METHODS: Three hundred and five (160 males; 145 females) adult type 2 diabetic Saudis participated in this cross-sectional study. Leptin, adiponectin, resistin, TNF-alpha and CRP were analysed, using enzyme-linked immunosorbent assays (ELISA). Each participant was screened for MS based on the definitions of WHO, AHA/NHLBI and IDF. RESULTS: IDF holds the most identified patients [190 (62.3%)] in both, males [107 (66.9%)], and females [83 (57.2%)]. In males, hyperleptinemia, hypoadiponectinemia and hyperresistinemia were strongest in the AHA/NHLBI-defined MS [odds ratio (95% confidence interval 'CI') of 2.03 (1.05-3.93); 1.31 (0.55-3.1); 1.63 (0.42-6.4) respectively]. The risk of elevated CRP was highest on the WHO definition [odds ratio (95% CI) of 2.04 (0.46-9.04)]. In females, the IDF-defined MS has the strongest association in all four parameters: odds ratio (95% CI), as follows: leptin [2.09 (0.14-30.71)]; adiponectin [6.00 (0.47-76.17)]; resistin [0.47 (0.18-1.23)] and CRP [3.07 (0.21-45.10)]. CONCLUSION: Gender differences exist in assessing the risk of various adipocytokine abnormalities in relation to the various criteria. This study supports the use of IDF definition among females and AHA/NHLBI in males in studies involving MS and obesity, since these definitions hold stronger predicting powers in detecting pathological levels of key adipocytokines. 2007 John Wiley & Sons, Ltd
Authors: Andrew A Butler; Charmaine S Tam; Kimber L Stanhope; Bruce M Wolfe; Mohamed R Ali; Majella O'Keeffe; Marie-Pierre St-Onge; Eric Ravussin; Peter J Havel Journal: J Clin Endocrinol Metab Date: 2012-08-07 Impact factor: 5.958
Authors: Kimber L Stanhope; Steven C Griffen; Andrew A Bremer; Roel G Vink; Ernst J Schaefer; Katsuyuki Nakajima; Jean-Marc Schwarz; Carine Beysen; Lars Berglund; Nancy L Keim; Peter J Havel Journal: Am J Clin Nutr Date: 2011-05-25 Impact factor: 7.045
Authors: Nasser M Al-Daghri; Shakilur Rahman; Osama E Amer; Omar S Al-Attas; Philip G McTernan; Majed S Alokail Journal: Int J Clin Exp Med Date: 2015-07-15
Authors: Nasser M Al-Daghri; Omar S Al-Attas; Majed S Alokail; Khalid M Alkharfy; Shaun Louie B Sabico; George P Chrousos Journal: PLoS One Date: 2010-08-13 Impact factor: 3.240
Authors: Kimber L Stanhope; Jean Marc Schwarz; Nancy L Keim; Steven C Griffen; Andrew A Bremer; James L Graham; Bonnie Hatcher; Chad L Cox; Artem Dyachenko; Wei Zhang; John P McGahan; Anthony Seibert; Ronald M Krauss; Sally Chiu; Ernst J Schaefer; Masumi Ai; Seiko Otokozawa; Katsuyuki Nakajima; Takamitsu Nakano; Carine Beysen; Marc K Hellerstein; Lars Berglund; Peter J Havel Journal: J Clin Invest Date: 2009-04-20 Impact factor: 14.808
Authors: Chad L Cox; Kimber L Stanhope; Jean Marc Schwarz; James L Graham; Bonnie Hatcher; Steven C Griffen; Andrew A Bremer; Lars Berglund; John P McGahan; Nancy L Keim; Peter J Havel Journal: Nutr Metab (Lond) Date: 2012-07-24 Impact factor: 4.169
Authors: Omar S Al-Attas; Nasser M Al-Daghri; Majed S Alokail; Assim Alfadda; Ahmed Bamakhramah; Shaun Sabico; Dave Pritlove; Alison Harte; Gyanendra Tripathi; Philip G McTernan; Sudhesh Kumar; George Chrousos Journal: Eur J Endocrinol Date: 2010-08-02 Impact factor: 6.664